Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi...

por Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F
Publicado 2017

Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start

por Ciurea, Adrian, Distler, Oliver, Kwok, Kenneth, Jo, Hyejin, Wang, Lisy, Killeen, Tim, Ospelt, Caroline, Frank Bertoncelj, Mojca
Publicado 2023

Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites

por Wang, Ellen Q., Le, Vu, O'Gorman, Melissa, Tripathy, Sakambari, Dowty, Martin E., Wang, Lisy, Malhotra, Bimal K.
Publicado 2021

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis

por Dougados, Maxime, Taylor, Peter C, Bingham, Clifton O, Fallon, Lara, Brault, Yves, Roychoudhury, Satrajit, Wang, Lisy, Kessouri, Meriem
Publicado 2022

Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized con...

por Li, Zhanguo, An, Yuan, Su, Houheng, Li, Xiangpei, Xu, Jianhua, Zheng, Yi, Li, Guiye, Kwok, Kenneth, Wang, Lisy, Wu, Qizhe
Publicado 2018

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years

por Pope, Janet E., Keystone, Edward, Jamal, Shahin, Wang, Lisy, Fallon, Lara, Woolcott, John, Lazariciu, Irina, Chapman, Douglass, Haraoui, Boulos
Publicado 2019

Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies

por van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley
Publicado 2020

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials

por Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Publicado 2020

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials

por Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
Publicado 2020

Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites

por Wang, Ellen Q., Le, Vu, Winton, Jennifer A., Tripathy, Sakambari, Raje, Sangeeta, Wang, Lisy, Dowty, Martin E., Malhotra, Bimal K.
Publicado 2022

Functional Assessment of Chronic Illness Therapy-Fatigue is a reliable and valid measure in patients with active ankylosing spondylitis

por Cella, David, Lenderking, William R., Chongpinitchai, Peter, Bushmakin, Andrew G., Dina, Oluwaseyi, Wang, Lisy, Cappelleri, Joseph C., Navarro-Compán, Victoria
Publicado 2022

Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme

por Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard
Publicado 2016

Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis

por Kaine, Jeffrey, Tesser, John, Takiya, Liza, DeMasi, Ryan, Wang, Lisy, Snyder, Mark, Soma, Koshika, Fan, Haiyun, Bandi, Vara, Wollenhaupt, Jürgen
Publicado 2020

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se...

por Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes
Publicado 2022

Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib

por Winthrop, Kevin L, Wouters, Ann, Choy, Ernest H, Chen, Connie, Biswas, Pinaki, Wang, Lisy, Soma, Koshika, Needle, Elie, Valdez, Hernan, Rigby, William FC
Publicado 2020

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib

por Dikranian, Ara, Gold, David, Bessette, Louis, Nash, Peter, Azevedo, Valderilio F., Wang, Lisy, Woolcott, John, Shapiro, Andrea B., Szumski, Annette, Fleishaker, Dona, Wollenhaupt, Jürgen
Publicado 2021

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

por Genovese, Mark C., van Vollenhoven, Ronald F., Wilkinson, Bethanie, Wang, Lisy, Zwillich, Samuel H., Gruben, David, Biswas, Pinaki, Riese, Richard, Takiya, Liza, Jones, Thomas V.
Publicado 2016

Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data

por Lee, Eun Bong, Yamanaka, Hisashi, Liu, Yi, Tsai, Wen‐Chan, Chen, Connie, Kwok, Kenneth, Yoo, Hyun–Jeong, Llamado, Lyndon J., Wang, Lisy, Luo, Yingchun, Sugiyama, Naonobu, Tanaka, Yoshiya
Publicado 2019

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

por Wollenhaupt, Jürgen, Lee, Eun-Bong, Curtis, Jeffrey R., Silverfield, Joel, Terry, Ketti, Soma, Koshika, Mojcik, Chris, DeMasi, Ryan, Strengholt, Sander, Kwok, Kenneth, Lazariciu, Irina, Wang, Lisy, Cohen, Stanley
Publicado 2019

Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis

por van Vollenhoven, Ronald, Lee, Eun Bong, Strengholt, Sander, Mojcik, Christopher, Valdez, Hernan, Krishnaswami, Sriram, Biswas, Pinaki, Lazariciu, Irina, Hazra, Anasuya, Clark, James D., Hodge, Jennifer, Wang, Lisy, Choy, Ernest
Publicado 2019